Patent · US Active

Reversible, parallel and multitask cloning method and kit

US9309518B2 · kind B2 · utility

0Cited by
12References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 25, 2012
Grant dateApr 12, 2016
Priority date
Expiry dateJun 21, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N15/70
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention is related to integrated method and tools to construct recombinant DNA molecules (to be used as DNA vaccine or gene therapy) without requiring the use of antibiotic(s) resistance gene(s) and without requiring the addition of one or more antibiotic(s) to the culture medium of cells submitted to this recombinant DNA method. The present invention allows to obtain the selection of recombinant host cell(s) transformed by a (exogenous) nucleic acid sequence of interest (extra-chromosomal vector containing the insert) and simultaneously stabilization (stable inheritance) of this (exogenous) nucleic acid sequence of interest into the transformed host cell(s) descendants (maintenance of the nucleic acid sequence of interest in the host cells population).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.